CTOs on the Move

The Araz Group

www.araz.com

 
The Araz Group is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.araz.com
  • 7201 W 78th St Ste 100
    Minneapolis, MN USA 55439
  • Phone: 952.896.1200

Executives

Name Title Contact Details

Similar Companies

Covance

As the drug development business of Laboratory Corporation of America Holdings (LabCorp) and the world’s most comprehensive drug development service company, we have helped pharmaceutical and biotech companies develop 100% of the top 50 prescription drugs in the marketplace today. Because of our broad experience and specialized expertise, we’re in a unique position to supply insights that go above and beyond testing. Together with our clients, we create solutions that transform potential into reality.

Expresso

Expresso fitness headquartered in Santa Clara, CA is the industry leader in gamified fitness for the commercial market. Over the past 15 years, Expresso has brought millions of riders adventure, challenges and community on their world class interactive connected bikes. The company is on a mission to bring people together through fitness with innovative, social, and immersive workouts. With over 100 million workouts where members ride in virtual worlds, push themselves with heart rate training, and HIIT workouts inspired by gaming, the company is well on its way to make that happen.

Excelin Health

Excelin Health owns and operates several quality home health agencies across the country.

Imagin Medical

Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.

Telesta Therapeutics

Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.